<i>Helicobacter pylori</i> eradication with proton pump inhibitor‐based triple therapies and re‐treatment with ranitidine bismuth citrate‐based triple therapy

Abstract

Our data found that this short-term triple therapy is not a satisfactory treatment (< 80% eradication rate) for H. pylori infection. The 2-week triple therapy used as re-treatment in eradication failure patients yielded more promising results.